ABEO - Abeona Therapeutics - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

42.35M

Cash

52.23M

Avg Qtr Burn

-9.252M

Short % of Float

10.80%

Insider Ownership

4.94%

Institutional Own.

60.31%

Qtr Updated

12/31/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
Pz-cel (prademagene zamikeracel) EB-101 (COL7A1) Details Recessive dystrophic epidermolysis bullosa	BLA Resubmission	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABO-102 (AAV-based Gene Therapy) Details Mucopolysaccharidosis type IIIA, Rare genetic disease, Rare diseases, Genetic disorder, Mucopolysaccharidoses	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
ABO-101 (AAV-based Gene Therapy) Details Rare diseases, Rare genetic disease, Genetic disorder, Mucopolysaccharidoses, Mucopolysaccharidosis type IIIB	Failed Discontinued	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.